1. Enforcement policy for viral transport media during the Coronavirus disease 2019 (COVID-19) public health emergency: guidance for commercial manufacturers, clinical laboratories, and Food and Drug Administration staff Publication: [Silver Spring, MD] : Center for Devices and Radiological Health, Office of Product Evaluation and Quality, July 2020 Subject(s): Culture MediaSpecimen HandlingTransportationVirus DiseasesCOVID-19United StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
2. Enforcement policy for viral transport media during the coronavirus disease 2019 (COVID19) public health emergency (revised): guidance for commercial manufacturers, clinical laboratories, and Food and Drug Administration staff Publication: [Silver Spring, MD] : Center for Devices and Radiological Health, November 2021 Subject(s): Culture MediaSpecimen HandlingTransportationVirus DiseasesCOVID-19United StatesUnited States. Department of Health and Human ServicesUnited States. Food and Drug Administration
3. Q5A(R2): viral safety evaluation of biotechnology products derived from cell lines of human or animal origin : guidance for industry Publication: Silver Spring, MD : Center for Drug Evaluation and Research, January 2024 Subject(s): BiotechnologyCell LineDrug IndustryGovernment RegulationSafetyVirus DiseasesUnited States
